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Abstract
Introduction: Hemangioblastomas are rare, benign tumors occurring in any part of the nervous system. Most are
found as sporadic tumors in the cerebellum or spinal cord. However, these neoplasms are also associated with von
Hippel-Lindau disease. We report a rare case of a sporadic sellar hemangioblastoma that became symptomatic due
to pituitary apoplexy.
Case presentation: An 80-year-old, otherwise healthy Caucasian woman presented to our facility with severe
headache attacks, hypocortisolism and blurred vision. A magnetic resonance imaging scan showed an acute
hemorrhage of a known, stable and asymptomatic sellar mass lesion with chiasmatic compression accounting for
our patient’s acute visual impairment. The tumor was resected by a transnasal, transsphenoidal approach and
histological examination revealed a capillary hemangioblastoma (World Health Organization grade I). Our patient
recovered well and substitutional therapy was started for panhypopituitarism. A follow-up magnetic resonance
imaging scan performed 16 months postoperatively showed good chiasmatic decompression with no tumor
recurrence.
Conclusions: A review of the literature confirmed supratentorial locations of hemangioblastomas to be very
unusual, especially within the sellar region. However, intrasellar hemangioblastoma must be considered in the
differential diagnosis of pituitary apoplexy.
Introduction
Hemangioblastomas (HBLs) are benign, slowly growing
and highly vascular tumors of the central nervous sys-
tem (CNS), accounting for just 1% to 2.5% of all intra-
cranial neoplasms, and 7% to 12% of primary tumors
located in the posterior fossa [1]. In up to one in four
cases of HBL there is an association with von Hippel-
Lindau (VHL) disease [2], ar a r ea u t o s o m a ld o m i n a n t
condition that predisposes patients to multisystemic
neoplastic disorders such as HBLs of the CNS, retinal
angiomas, renal cell carcinoma, pheochromocytomas,
serous cystadenomas and neuroendocrine tumors of the
pancreas. VHL-associated HBLs tend to occur in
younger patients and are often multiple in occurrence
[2-4]. Sporadic HBLs, however, are mostly solitary
lesions and predominantly found within the cerebellum
or spinal cord. Supratentorial HBLs, which are more
often associated with VHL disease [3,4], are a rare entity
with just over 100 reported cases to date [5]. HBLs ori-
ginating from the sellar or suprasellar region are excep-
tional, especially in cases with no association with VHL
disease.
We report here what is, to the best of our knowledge,
the seventh sporadic case in the literature of sellar HBL,
which presented with pituitary apoplexy. We also review
the literature on cases of HBL within the sellar and
suprasellar region.
Case presentation
An 80-year-old Caucasian woman was admitted to our
hospital with a 12-year history of an endocrine inactive
steady sellar mass lesion (13 mm in diameter; Figure
1A, B). Our patient had been previously asymptomatic
with no pituitary hormone deficiency or visual impair-
ments. Moreover, our patient had a medical history of
good health with only minor health issues that included
hypertension and osteoporosis. However, prior to hospi-
tal admission, she had recently experienced two severe
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any medium, provided the original work is properly cited.Figure 1 MRI images of patient’s brain. (A, B) T1- and T2- weighted MRI scans taken two years prior to current presentation. (C) T1-weighted
MRI scan of patient’s brain, revealing a partly vesicular hyperintense, and slightly increased (compared to A and B) intrasellar and suprasellar
mass of 16 mm in diameter, with progressive compression of the prechiasmatic portions of her optic nerves bilaterally. (D) T2-weighted MRI
scan showing the vesicular portion as hypointense; normal pituitary tissue could not be clearly delineated. (E, F) There was no evident
enhancement on T1-weighted imaging after intravenous administration of gadolinium. (G, H) An MRI scan taken 16 months postoperatively
showed regular display of the remaining pituitary gland with good chiasmatic decompression and no signs of tumor recurrence.
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nausea, vomiting and blurred vision. Hyponatremia (120
mEq/L) with low serum osmolality (247 mOsm/L) and
highly elevated urine osmolality (695 mOsm/L) were
detected. An endocrinological investigation revealed
hypocortisolism with no other hormone disturbances.
Fundoscopy showed no pathological findings. However,
further ophthalmologic examination with Goldman peri-
metry confirmed a bitemporal hemianopsia accentuated
on her right side. Her neurological examination results
were otherwise normal. After substitution therapy with
hydrocortisone, our patient rapidly improved and her
headaches subsided.
Findings from a magnetic resonance imaging (MRI)
scan were suggestive of an acute hemorrhage of the
sellar process, consistent with pituitary apoplexy (Figure
1C-F). Except for an age-consistent vascular leukoence-
phalopathy, the diagnostic imaging showed no further
pathological findings. Our tentative diagnosis at this
point was a pituitary adenoma with pituitary apoplexy.
Due to these clinical and radiological findings, the
decision was made to surgically remove the tumor. A
gross total extirpation using a transnasal, transsphenoi-
dal approach to the pituitary mass was successfully per-
formed. Intraoperatively, the tumor appeared yellowish-
brown, was relatively firm and was located within a
sellar hematoma cavity, which was evacuated.
Postoperatively, our patient’s visual field deficits
improved markedly on clinical examination and Gold-
man perimetry confirmed a partial recovery of her
bitemporal visual field deficits. Endocrinological studies
showed panhypopituitarism with partial and transient
diabetes insipidus. Our patient received substitution
therapy with hydrocortisone, levothyroxine and transient
therapy with desmopressin. Overall, our patient
remained in good health with a satisfactory level of per-
formance. A repeat MRI scan taken 16 months after
surgery showed good chiasmatic decompression with no
residual tumor mass (Figure 1G, H).
The resected tumor was examined with light micro-
scopy, which revealed a small, well circumscribed, non-
adenomatous tumor surrounded by slightly compressed
remnants of adenohypophyseal parenchyma (Figure 2A-
C). The tumor was richly vascularized with an observa-
ble reticular mesh of thin-walled capillaries interspersed
with large epithelioid-looking cells (Figure 2D, E). Pale
eosinophilic cytoplasm showed xanthomatous or vacuo-
lar change (Figure 2F). Immunohistochemistry con-
firmed the expression of the endothelial-associated
markers CD31 and CD34 in the intratumoral capillaries,
although not in the stromal cells themselves. Conversely,
the stromal cells were diffusely immunoreactive for
vimentin, with a minority of cells also coexpressing
S100 protein and epithelial membrane antigen (Figure
2G). No inflammatory infiltrate was detected except for
the occasional mast cell (Figure 2H). Staining for cyto-
keratins tested negative, as did the Langerhans-cell-asso-
ciated marker CD1a. Less than 1% of lesional cell nuclei
were labeled with the cell proliferation-associated anti-
gen Ki-67.
Given the above findings, we identified the tumor as
an intrapituitary example of capillary hemangioblastoma
(World Health Organization grade I). Since our patient
displayed no clinical stigmata of VHL disease, genetic
testing was not performed.
Discussion
Based on previous studies, the occurrence of supraten-
torial HBLs is thought to be in the range of 2% to 8% of
all HBLs [3,4,6], accounting for 116 reported cases from
1902 to 2004 [5]. Supratentorial tumors were mostly
found in the frontal, parietal or temporal lobes [7].
No more than 27 reported cases to date (including our
patient’s case) describe HBLs originating in the sellar
and suprasellar region (see [1] and references therein,
and [2,8-11]) of which 18 were confirmed with histo-
pathology (Table 1). Of the 27 cases, only seven (26%)
were sporadic. In accordance with previous studies, the
average age at presentation of patients with sporadic
HBLs (52.4 years) was greater than patients affected
with the VHL syndrome (35.8 years), excluding two
cases with postmortem diagnosis (Table 1, cases 1 and
2) and one case not stating VHL association [10].
While information on clinical features is derived from
reports of sellar and suprasellar HBLs causing symptoms
generally related to mass effect, a long presymptomatic
stage can be assumed. Of a total of 250 patients with VHL
disease enrolled in a prospective study, eight incidentally
discovered HBLs located in the pituitary stalk remained
stable during a mean follow-up of 41.4 ± 14 months [8].
Also, in our patient’s case, the sellar lesion, initially diag-
nosed as an incidental finding on MRI performed for an
unrelated reason, remained stable for 12 years.
Overall, the unexpected nature and the unspecific pre-
sentation render an accurate preoperative diagnosis of
sporadic HBLs challenging. In our patient, the apoplexy
of a well known sellar mass suggested a pituitary macro-
adenoma; clinical apoplexy was observed in 0.6% to 9.0%
of these cases [12]. The typical, albeit not pathognomo-
nic, radiological feature of HBLs is that they can be
identified as an enhancing lesion on T1-weighted MRI
scans. This finding was lacking in our case due to acute
hemorrhage of the lesion.
The main histological differential diagnosis of HBL,
irrespective of location, is metastatic clear cell carci-
noma. In our patient, lack of immunoreactivity for cyto-
keratins along with a negligibly low proliferation index
allowed for this alternative to be confidently ruled out.
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also addressed the possibility of xanthomatous hypophy-
sitis and Langerhans cell histiocytosis [13,14]. The non-
inflammatory character of the lesion in our case strongly
argued against xanthomatous hypophysitis (or sellar
xanthogranuloma). However, the circumscribed rather
than infiltrative pattern of this solitary intrapituitary
nodule, one devoid of CD1a immunoreactivity, was an
intuitive obstacle against seriously considering Langer-
hans cell histiocytosis.
Conclusions
Supratentorial HBLs are rare, especially within the sellar
region and without an association with VHL disease.
However, our patient’s case shows that intrasellar HBL
must be considered in the differential diagnosis of pitui-
tary apoplexy.
Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
Figure 2 Overview showing well circumscribed HBL nodule partly surrounded by a crescent-shaped mantle of peritumoral pituitary
parenchyma. (A) Optical contrast between the faint eosinophilic hue of the HBL nidus and bright red granular quality of adjacent
somatotrophs. (B, C) Adjacent section planes treated with immunohistochemistry, showing segregation of adenohypophyseal neuroendocrine
cells (B) and mesenchymal-like immunophenotype (C) of the HBL nodule. (D) Detail view of boxed area in (A) shows the HBL to be comprised
of an irregular reticular meshwork of tortuous, thin-walled capillaries that tend to be interspersed with pale stromal cells. (E) Gomori’s reticulin
stain highlighting the brisk transition from the acinar outline of native adenohypophyseal follicles (upper third) to the vascular-dominated
basement membrane pattern of HBL. (F) High-power view of HBL showing polygonal contours and cytoplasmic vacuolation of stromal cells
encased by capillaries. Some nuclear pleomorphism, as also evident in this microscopic field, is of no prognostic significance. (G) A minority of
stromal cells were stained for epithelial membrane antigen. (H) Scattered mast cells are a characteristic complement of HBL. If not labeled
otherwise, microphotographs have been made using hematoxylin and eosin stain. Original magnifications: (A-C) × 30; (D, E, H) × 100; (F, G) ×
400.
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review by the Editor-in-Chief of this journal.
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Table 1 Literature review of reported cases of HBL confirmed by histopathology in the sellar region
Case Reference Age
(years),
sex
Symptoms Location VHL Surgery for
sellar HBL
Follow-up
1 [15] 84, M None Intrasellar
(anterior
lobe)
Yes None, autoptic
finding
NA
2 [16] 26, M Blurred vision, headache, ataxia Intrasellar
(anterior
lobe)
Yes None, autoptic
finding
NA
3 [17] 19, M Nausea, vertigo, ataxia Suprasellar Yes Total resection NA
4 [18] 19, F Headache, amenorrhea-galactorrhea Pituitary
stalk
No Total resection Panhypopituitarism
5 [2] 35, F Headache, amenorrhea, diabetes
insipidus
Pituitary
stalk
No Yes, details NA NA
6 [9] 60, F Partial hemianopsia Suprasellar Yes None, gamma
knife radiosurgery
Syndrome of inappropriate secretion of
antidiuretic hormone at 22-month follow-
up
7 [19] 11, F Headache, bitemporal hemianopsia,
adrenocorticotropic hormone and
growth hormone deficiency
Intrasellar Yes Subtotal resection
and adjuvant
radiosurgery
Headache improved, no residual tumor,
panhypopituitarism
8 [20] 57, F Diplopia, sixth nerve palsy Intrasellar
and
sphenoid
sinus
No Subtotal resection Partial improvement of sixth nerve palsy
9 [21] 20, F Panhypopituitarism, diabetes
insipidus
Suprasellar
and
pituitary
stalk
Yes Total resection Stable panhypopituitarism, no residual
tumor at 53-month follow-up
10 [22] 33, F Irregular menses Pituitary
stalk
Yes Subtotal resection No neurological deficits or pituitary
dysfunction, stable residual tumor at six-
month follow-up
11 [23] 62, M Visual disturbance Suprasellar No Total resection NA
12 [24] 60, M Bitemporal hemianopsia,
panhypopituitarism
Intrasellar
and
suprasellar
No Transsphenoidal
biopsy
NA
13 [25] 40, F Oligomenorrhea, cognitive
impairment
Intrasellar
and
suprasellar
Yes Subtotal resection
and gamma knife
radiosurgery
NA
14 [26] 54, M Headache, visual loss Suprasellar No Total resection Partial improvement of visual loss, no
tumor recurrence at five-year follow-up
15 [26] 38, M Headache, visual loss Suprasellar Yes Subtotal resection NA
16 [1] 51, F Blurred vision Pituitary
stalk
Yes Total resection Panhypopituitarism, visual acuity
improved
17 [27] 59, F Fatigue, visual loss Suprasellar NS Total resection Panhypopituitarism, no tumor recurrence
at three-year follow-up
18 Present
case
80, F Headache, bitemporal hemianopsia,
hypocortisolism
Intrasellar No Total resection Headache subsided, visual field deficits
improved, panhypopituitarism, no tumor
recurrence at 16-month follow-up
F: female patient; M: male patient; NA: not available.
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